Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Wiegand is active.

Publication


Featured researches published by M. Wiegand.


Biological Psychiatry | 1991

From Early to Late Adulthood Changes in EEG Sleep of Depressed Patients and Healthy Volunteers

Christoph J. Lauer; Dieter Riemann; M. Wiegand; Mathias Berger

In order to evaluate the impact of aging on EEG sleep patterns we investigated the polysomnograms of 74 patients with major depression and 51 healthy volunteers aged 18-65 years. In most of the EEG sleep parameters, age-related changes were obvious in both the depressives and the normals. In the patients, some of these alterations occurred earlier and were more pronounced. The amount of slow-wave sleep decreased with age, but no differences were found between the depressives and the healthy volunteers at any particular age. Rapid-eye-movement (REM) latency was clearly affected by age, but there were no significant differences between patients and controls until the middle of the fourth decade of life. On the other hand, REM density measures did not vary with age and were increased in the depressives. Therefore, REM density appears to be a more likely candidate for a biologic marker for major depression than is REM latency.


Journal of Neurology | 1991

Nocturnal sleep in huntington's disease

M. Wiegand; A. A. Möller; Christoph J. Lauer; S. Stolz; Wolfgang Schreiber; M. Dose; Jürgen-Christian Krieg

SummaryNocturnal sleep was studied in 16 inpatients with Huntingtons disease. In comparison with healthy controls, patients exhibited a disturbed sleep pattern with increased sleep onset latency, reduced sleep efficiency, frequent nocturnal awakenings, more time spent awake and less slow wave sleep. These abnormalities correlated in part with duration of illness, severity of clinical symptoms, and degree of atrophy of the caudate nucleus. Patients showed an increased density of sleep spindles.


Biological Psychiatry | 1987

The influence of daytime naps on the therapeutic effect of sleep deprivation

M. Wiegand; Mathias Berger; Jiirgen Zulley; Christoph J. Lauer; Detlev von Zerssen

Hillhouse EW, Burden J, Jones MT (1975): The effect of various putative neurotransmitters on the release of corticotrophin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline. Neuroendocrimlogy 17:1-11. Hoehn MM, Yahr MD (1967): Parkinsonism: Onset, progression, and mortality. Neurology 17:427-442. Lamberts SWJ, Klijn JGM, de Quijada M, Timmermans HAT, Uitterlinden P, de Jong FH, Birkenhager JC (1980): The mechanism of the suppressive action of bromoctiptine on adrenocorticotrophin secretion in patients with Cushing’s disease and Nelson’s syndrome. J Clin Enabcrinol Metab 51:307-311.


Biological Psychiatry | 1993

Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression

M. Wiegand; Dieter Riemann; Wolfgang Schreiber; Christoph J. Lauer; Mathias Berger

In 30 depressed patients who had responded to total sleep deprivation therapy, morning naps led more frequently to relapses into depression than did afternoon naps. Longer naps were less detrimental than shorter ones, and there was no significant relationship between the effect of a nap on mood and its content of slow-wave-sleep. The amount of the rapid eye-movement sleep, too, was unrelated to clinical nap effects. Thus, some of the current theories on the relationship between sleep and depressive symptomatology are not supported by the data. Our results demonstrate the importance of nap timing, suggesting a circadian variation of propensity to relapse into depression.


European Archives of Psychiatry and Clinical Neuroscience | 1991

Nocturnal sleep EEG in patients with HIV infection

M. Wiegand; A. A. Möller; Wolfgang Schreiber; Jürgen C. Krieg; Dietmar Fuchs; Helmut Wachter; Florian Holsboer

SummaryNocturnal sleep was studied in 14 human immunodeficiency virus (HIV)-positive patients without opportunistic infections of the central nervous system. Seven patients had no bodily complaints at the time of the investigation. Patients exhibited an impaired nocturnal sleep with longer sleep onset latency, reduced total sleep time, reduced sleep efficiency, and more time spent awake and in stage 1. Stage 2 sleep was significantly decreased; in 2 cases, sleep spindle density was extremely low. REM latency was reduced and correlated negatively with depressive symptomatology, while the percentages of REM and slow wave sleep were normal. No significant differences in sleep parameters were present among patients in different stages of the illness, or between patients with and without bodily complaints. Ventricular size and sulcal width on computed tomography scans correlated with sleep variables indicating reduced sleep quality, and with REM density. Decreased tryptophan plasma levels were associated with shorter and less efficient sleep, and with reduced stage 2 sleep. The findings demonstrate that sleep EEG investigations can be valuable for detecting and monitoring central nervous system affection in HIV-positive individuals.


Acta Neurologica Scandinavica | 1991

Alterations of nocturnal sleep in patients with HIV infection

M. Wiegand; A. A. Möller; Wolfgang Schreiber; Jürgen-Christian Krieg; Florian Holsboer

Nocturnal sleep of 14 patients with HIV infection was characterized by longer sleep onset latency, shorter total sleep time, reduced sleep efficiency, more time spent awake and in Stage 1. There was significantly less sleep Stage 2 than in healthy controls. REM latency was slightly reduced and correlated negatively with depressive symptomatology, while percentages of REM and slow wave sleep were normal. Patients without complaints at the time of the investigation exhibited similar sleep abnormalities. The results stress the usefulness of polysomnography as a sensitive methodology for detection and monitoring of CNS affection in HIV positive patients.


European Archives of Psychiatry and Clinical Neuroscience | 1991

Brain morphology and sleep EEG in patients with Huntington's disease.

M. Wiegand; A. A. Möller; Wolfgang Schreiber; Christoph J. Lauer; Jürgen-Christian Krieg

SummaryIn 12 patients with Huntingtons disease, the relationship between brain morphology, nocturnal sleep EEG, and clinical variables was studied. Global cerebral atrophy did not significantly correlate with sleep parameters, whereas atrophy of the caudate nuclei was associated with reduced slow wave sleep and increased time spent awake. Several clinical parameters (e.g., anergia and thought disturbance scores of the Brief Psychiatric Rating Scale, illness duration and global clinical assessment) showed significant correlations with global cerebral atrophy. Similar studies in other neuropsychiatric disorders demonstrate associations between sleep alterations and brain morphological changes of different localizations, thus pointing to a complex relationship between both. It can be hypothesized that the caudate nuclei may be involved in sleep regulation; indirect evidence from studies with positron emission tomography (PET) point in the same direction.


European Archives of Psychiatry and Clinical Neuroscience | 1992

All-night electroencephalographic sleep and cranial computed tomography in depression: A study of unipolar and bipolar patients

Christoph J. Lauer; M. Wiegand; Jürgen-Christian Krieg

SummaryAll-night electroencephalographic (EEG) sleep recording and cranial computed tomography were performed in 24 inpatients with major depression (14 unipolar, 10 bipolar). The patients showed the characteristic “depression-like” EEG sleep alterations and their ventricular brain ratio (VBR) was increased compared with the control subjects. No major differences were found between the unipolar and the bipolar groups. There was a close and positive association between the VBR values and several measures of slow wave sleep. It is hypothesized that this relationship is due to an altered function of the limbic-hypothalamic-pituitary-adrenocortical axis in depression that affects both EEG sleep and brain morphology.


Drugs | 1989

Action of Trimipramine on Sleep and Pituitary Hormone Secretion

M. Wiegand; Mathias Berger

SummaryTrimipramine is unlike other antidepressants in that it does not suppress REM sleep and possesses an atypical pharmacological profile. This antidepressant was administered in the evening to 10 depressed patients at a dosage of 75mg on night 1 with 25mg increments each night, up to 200mg on night 6 and at this dosage thereafter. Sleep parameters were measured at baseline and on nights 2, 11 and 21. On nights 11 and 21, there was a significantly improved sleep pattern as shown by increases in sleep period time, total sleep time and sleep efficiency, and there was a decrease in sleep onset latency. No suppression of REM sleep occurred, and an increase was even noted; this, however, may have been due to a particularly low baseline value. Subjective assessments in which self-ratings of sleep quality were used also demonstrated an improvement in sleep. In addition, the neuroendocrine effects of trimipramine were investigated in 8 healthy volunteers after a single oral 75mg dose. After 3 hours, a significant fall in plasma cortisol concentration from 117 to 43 µg/L and a significant rise in plasma prolactin concentration from 6 to 16.3 µg/L were observed, but there was no significant effect on plasma human growth hormone concentration.These results further support the effectiveness of trimipramine therapy in normalising a disturbed sleep pattern in depressed patients, and it may be of use in non-depressed insomniacs. The acute neuroendocrine effects of trimipramine are similar to those observed with neuroleptics and further indicate its atypical pharmacological profile.


Behaviour Research and Therapy | 1992

Predictors of short-term treatment outcome in bulimia nervosa inpatients

Sabine Bossert; Ulrike Schmölz; M. Wiegand; Mathias Junker; Jürgen-Christian Krieg

Recent studies, mostly performed on bulimic outpatients, did not find consistent predictors of treatment outcome in bulimia nervosa. This is the first study to investigate anamnestic and clinical factors predictive of the short-term outcome of hospital treatment in 31 female bulimia nervosa patients with a mean age of 22.9 yr. Treatment outcome was assessed by several self-rating instruments measuring different features of the specific and unspecific psychopathology of bulimia nervosa. The most relevant predictors of the outcome of the 8-week hospital treatment were duration of previous inpatient treatments for bulimia, the intensity of anorexic tendency and the pretreatment level of depression. The majority of predictors tested did not show a strong relationship to treatment outcome. The findings are discussed in relation to results of other studies as well as to possible implications for treatment and research.

Collaboration


Dive into the M. Wiegand's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jürgen Zulley

University of Regensburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge